Approval · Notice of Compliance 4658 · 1996
INVIRASE: Notice of Compliance 4658
Issued March 22, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4658
- Date
- March 22, 1996
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- HIV protease inhibitor/antiretroviral
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INVIRASE | 02216965 | Cancelled Post Market |
Medicinal ingredients
- SAQUINAVIR MESYLATE 200 MG per CAP